A detailed history of Keystone Financial Group transactions in Merck & Co., Inc. stock. As of the latest transaction made, Keystone Financial Group holds 27,008 shares of MRK stock, worth $2.66 Million. This represents 1.04% of its overall portfolio holdings.

Number of Shares
27,008
Previous 26,494 1.94%
Holding current value
$2.66 Million
Previous $3.28 Million 6.47%
% of portfolio
1.04%
Previous 1.2%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $57,131 - $66,290
514 Added 1.94%
27,008 $3.07 Million
Q2 2024

Jul 31, 2024

BUY
$123.8 - $132.96 $247 - $265
2 Added 0.01%
26,494 $3.28 Million
Q1 2024

May 08, 2024

BUY
$113.24 - $131.95 $78,815 - $91,837
696 Added 2.7%
26,492 $3.5 Million
Q4 2023

Feb 09, 2024

SELL
$100.18 - $109.02 $98,877 - $107,602
-987 Reduced 3.69%
25,796 $2.81 Million
Q3 2023

Nov 06, 2023

SELL
$102.95 - $114.33 $6,279 - $6,974
-61 Reduced 0.23%
26,783 $2.76 Million
Q2 2023

Aug 07, 2023

BUY
$108.61 - $118.38 $43,552 - $47,470
401 Added 1.52%
26,844 $3.1 Million
Q4 2022

Feb 07, 2023

BUY
$87.44 - $112.11 $90,063 - $115,473
1,030 Added 4.05%
26,443 $2.93 Million
Q3 2022

Nov 10, 2022

BUY
$84.53 - $94.96 $53,507 - $60,109
633 Added 2.55%
25,413 $2.19 Million
Q2 2022

Aug 05, 2022

SELL
$83.49 - $94.64 $10,686 - $12,113
-128 Reduced 0.51%
24,780 $2.26 Million
Q1 2022

May 13, 2022

BUY
$73.51 - $82.4 $5,439 - $6,097
74 Added 0.3%
24,908 $2.04 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $4,842 - $6,066
67 Added 0.27%
24,834 $1.9 Million
Q3 2021

Nov 12, 2021

BUY
$71.68 - $78.83 $10,106 - $11,115
141 Added 0.57%
24,767 $1.86 Million
Q2 2021

Aug 13, 2021

BUY
$70.31 - $77.77 $158,056 - $174,826
2,248 Added 10.05%
24,626 $1.92 Million
Q1 2021

May 11, 2021

SELL
$68.86 - $81.11 $79,395 - $93,519
-1,153 Reduced 4.9%
22,378 $1.73 Million
Q4 2020

Feb 10, 2021

BUY
$71.77 - $79.65 $30,789 - $34,169
429 Added 1.86%
23,531 $1.93 Million
Q3 2020

Nov 13, 2020

SELL
$73.18 - $82.95 $17,636 - $19,990
-241 Reduced 1.03%
23,102 $1.92 Million
Q2 2020

Aug 13, 2020

SELL
$70.42 - $80.13 $5,211 - $5,929
-74 Reduced 0.32%
23,343 $1.81 Million
Q1 2020

May 05, 2020

BUY
$63.36 - $87.82 $171,959 - $238,343
2,714 Added 13.11%
23,417 $1.8 Million
Q4 2019

Feb 06, 2020

BUY
$77.58 - $87.54 $543 - $612
7 Added 0.03%
20,703 $1.88 Million
Q3 2019

Nov 07, 2019

BUY
$76.08 - $82.93 $10,118 - $11,029
133 Added 0.65%
20,696 $1.74 Million
Q2 2019

Aug 07, 2019

BUY
$69.84 - $81.59 $4,958 - $5,792
71 Added 0.35%
20,563 $1.72 Million
Q1 2019

May 07, 2019

BUY
$69.58 - $79.36 $400,989 - $457,351
5,763 Added 39.13%
20,492 $1.7 Million
Q4 2018

Feb 11, 2019

BUY
$65.24 - $75.71 $65,305 - $75,785
1,001 Added 7.29%
14,729 $1.13 Million
Q3 2018

Nov 06, 2018

BUY
$57.69 - $67.84 $791,968 - $931,307
13,728 New
13,728 $982,000

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $249B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Keystone Financial Group Portfolio

Follow Keystone Financial Group and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Keystone Financial Group, based on Form 13F filings with the SEC.

News

Stay updated on Keystone Financial Group with notifications on news.